Tobacco smoking cessation management: integrating varenicline in current practice
Laurence M GalantiClinique Universitaire UCL, Mont-Godinne, Yvoir, BelgiumAbstract: Tobacco smoking is widespread and is one of the world’s most prevalent modifiable risk factors for morbidity and mortality. It is important to facilitate smoking cessation better in order to reduce the heal...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-08-01
|
| Series: | Vascular Health and Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/tobacco-smoking-cessation-management-integrating-varenicline-in-curren-peer-reviewed-article-VHRM |
| _version_ | 1819114238496473088 |
|---|---|
| author | Laurence M Galanti |
| author_facet | Laurence M Galanti |
| author_sort | Laurence M Galanti |
| collection | DOAJ |
| description | Laurence M GalantiClinique Universitaire UCL, Mont-Godinne, Yvoir, BelgiumAbstract: Tobacco smoking is widespread and is one of the world’s most prevalent modifiable risk factors for morbidity and mortality. It is important to facilitate smoking cessation better in order to reduce the health consequences of tobacco use. The most effective approach assisting smokers in their quit attempts combines both pharmacotherapy and nonpharmacological interventions. This review summarizes the latest international epidemiological data available on tobacco use, considers the associated effects on health, and reviews existing policies against tobacco use. Among the interventions for smoking cessation, the three major pharmacotherapies (which have demonstrated efficacy when combined with behavioral support) are discussed: nicotine replacement therapy (NRT), bupropion, and varenicline. As the newest pharmacotherapy made available in this area, particular consideration is given to varenicline, and a review of our clinical experience is offered.Keywords: tobacco smoking cessation, nicotinic substitution, nicotine replacement therapy (NRT), bupropion, varenicline |
| first_indexed | 2024-12-22T04:42:07Z |
| format | Article |
| id | doaj.art-27997a8e082f4349839e038b01d3594b |
| institution | Directory Open Access Journal |
| issn | 1178-2048 |
| language | English |
| last_indexed | 2024-12-22T04:42:07Z |
| publishDate | 2008-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Vascular Health and Risk Management |
| spelling | doaj.art-27997a8e082f4349839e038b01d3594b2022-12-21T18:38:42ZengDove Medical PressVascular Health and Risk Management1178-20482008-08-01Volume 48378452171Tobacco smoking cessation management: integrating varenicline in current practiceLaurence M GalantiLaurence M GalantiClinique Universitaire UCL, Mont-Godinne, Yvoir, BelgiumAbstract: Tobacco smoking is widespread and is one of the world’s most prevalent modifiable risk factors for morbidity and mortality. It is important to facilitate smoking cessation better in order to reduce the health consequences of tobacco use. The most effective approach assisting smokers in their quit attempts combines both pharmacotherapy and nonpharmacological interventions. This review summarizes the latest international epidemiological data available on tobacco use, considers the associated effects on health, and reviews existing policies against tobacco use. Among the interventions for smoking cessation, the three major pharmacotherapies (which have demonstrated efficacy when combined with behavioral support) are discussed: nicotine replacement therapy (NRT), bupropion, and varenicline. As the newest pharmacotherapy made available in this area, particular consideration is given to varenicline, and a review of our clinical experience is offered.Keywords: tobacco smoking cessation, nicotinic substitution, nicotine replacement therapy (NRT), bupropion, vareniclinehttps://www.dovepress.com/tobacco-smoking-cessation-management-integrating-varenicline-in-curren-peer-reviewed-article-VHRMtobacco smoking cessationnicotinic substitutionnicotine replacement therapy (NRT)bupropionvarenicline |
| spellingShingle | Laurence M Galanti Tobacco smoking cessation management: integrating varenicline in current practice Vascular Health and Risk Management tobacco smoking cessation nicotinic substitution nicotine replacement therapy (NRT) bupropion varenicline |
| title | Tobacco smoking cessation management: integrating varenicline in current practice |
| title_full | Tobacco smoking cessation management: integrating varenicline in current practice |
| title_fullStr | Tobacco smoking cessation management: integrating varenicline in current practice |
| title_full_unstemmed | Tobacco smoking cessation management: integrating varenicline in current practice |
| title_short | Tobacco smoking cessation management: integrating varenicline in current practice |
| title_sort | tobacco smoking cessation management integrating varenicline in current practice |
| topic | tobacco smoking cessation nicotinic substitution nicotine replacement therapy (NRT) bupropion varenicline |
| url | https://www.dovepress.com/tobacco-smoking-cessation-management-integrating-varenicline-in-curren-peer-reviewed-article-VHRM |
| work_keys_str_mv | AT laurencemgalanti tobaccosmokingcessationmanagementintegratingvareniclineincurrentpractice |